Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.99 is 24% below its 5-year average of 3.95, near the low end of its 5-year range (0.74–11.76).
As of the fiscal period ended Tuesday, June 30, 2026. 111.37% above its 12-month average of 1.41.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.99.
CURRENT RATIO
2.99
CURRENT RATIO AVG TTM
1.41
CURRENT RATIO AVG 3Y
1.00
CURRENT RATIO AVG 5Y
3.95
CURRENT RATIO AVG 10Y
7.80
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+111.37%
CURRENT VS 3Y AVG
+199.69%
CURRENT VS 5Y AVG
-24.30%
CURRENT VS 10Y AVG
-61.67%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.00
median of 343 covered companies
CURRENT VS SECTOR MEDIAN
-0.30%
vs the sector median at left
Market Cap
$14.97B
Current Ratio
1.35
TTM Avg
1.35
3Y Avg
1.39
5Y Avg
1.37
Market Cap
$13.19B
Current Ratio
2.86
TTM Avg
3.13
3Y Avg
4.39
5Y Avg
5.54
Market Cap
$12.89B
Current Ratio
0.95
TTM Avg
1.18
3Y Avg
1.19
5Y Avg
1.30
Market Cap
$12.52B
Current Ratio
1.95
TTM Avg
1.83
3Y Avg
1.71
5Y Avg
1.91
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ascendis Pharma A/S (ASND) | $14.16B | 2.99 | 1.41 | 1.00 | 3.95 |
| Tempus AI, Inc. (TEM)vs › | $14.64B | 3.30 | 2.71 | 2.36 | 3.23 |
| Exelixis, Inc. (EXEL)vs › | $14.79B | 3.46 | 3.59 | 3.51 | 4.19 |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.97B | 1.35 | 1.35 | 1.39 | 1.37 |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 2.86 | 3.13 | 4.39 | 5.54 |
| Solventum Corporation (SOLV)vs › | $15.24B | 1.02 | 1.21 | 1.40 | 1.43 |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | 1.23 | 3.65 | 3.78 | 4.74 |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 0.95 | 1.18 | 1.19 | 1.30 |
| Baxter International Inc. (BAX)vs › | $12.52B | 1.95 | 1.83 | 1.71 | 1.91 |
| Penumbra, Inc. (PEN)vs › | $12.49B | 5.75 | 6.32 | 5.98 | 5.88 |
Current Ratio
2.99
Quick Ratio
2.32
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.99 |
| 2026-03-31 | 1.00 |
| 2025-12-31 | 1.04 |
| 2025-09-30 | 1.03 |
| 2025-06-30 | 1.02 |
| 2025-03-31 | 1.04 |
| 2024-12-31 | 1.17 |
| 2024-09-30 | 1.16 |
| 2024-06-30 | 0.74 |
| 2024-03-31 | 0.83 |
| 2023-12-31 | 0.95 |
| 2023-09-30 | 3.44 |
| 2023-06-30 | 3.52 |
| 2023-03-31 | 4.08 |
| 2022-12-31 | 5.39 |
| 2022-09-30 | 7.56 |
| 2022-06-30 | 9.66 |
| 2022-03-31 | 11.76 |
| 2021-12-31 | 8.03 |
| 2021-09-30 | 8.24 |
| 2021-06-30 | 8.31 |
| 2021-03-31 | 9.42 |
| 2020-12-31 | 14.02 |
| 2020-09-30 | 14.80 |
| 2020-06-30 | 9.04 |
| 2020-03-31 | 13.19 |
| 2019-12-31 | 12.74 |
| 2019-09-30 | 15.74 |
| 2019-06-30 | 11.59 |
| 2019-03-31 | 22.32 |
| 2018-12-31 | 7.53 |
| 2018-09-30 | 10.54 |
| 2018-06-30 | 9.87 |
| 2018-03-31 | 20.55 |
| 2017-12-31 | 8.61 |
| 2017-09-30 | 10.85 |
| 2017-06-30 | 8.54 |
| 2017-03-31 | 9.28 |
| 2016-12-31 | 13.67 |
| 2016-09-30 | 6.52 |
| 2016-06-30 | 8.16 |
| 2016-03-31 | 9.90 |
| 2015-12-31 | 10.98 |
| 2015-09-30 | 14.18 |
| 2015-06-30 | 11.49 |
| 2015-03-31 | 12.88 |
| 2014-12-31 | 4.13 |
| 2014-09-30 | 0.77 |
| 2014-06-30 | 0.90 |
| 2014-03-31 | 0.00 |
| 2013-12-31 | 1.04 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
